SINUVA Sinus Implant Treatment
Are you still living with nasal polyps?
Nasal polyp symptoms often make it difficult to breathe and reduce sense of smell, impacting everyday life.
How can Sinuva treat sinus polyps for good?
SINUVA Sinus Implant Treatment FAQ
Sinuva expands in the ethmoid sinus and delivers anti-inflammatory medicine directly to the nasal polyps, not to the rest of your body.*
- It does not have to be taken routinely to deliver anti-inflammatory medicine 24/7 for up to 90 days.
- Is not a saline rinse, steroid spray, oral steroid, injectable medication, or sinus surgery.
It’s an in-office alternative to repeat sinus surgery for nasal polyps.
* Anti-inflammatory medicine (mometasone furoate) was not detected 14 days after placement of SINUVA in a pharmacokinetics study.
Why choose Sinuva?
SINUVA is an option for the treatment of nasal polyps that’s been shown to provide effective relief, compared to daily steroid nasal spray† alone in a clinical trial with 300 patients:
- Proven to shrink nasal polyps
Reduced symptoms of nasal obstruction and congestion for up to 90 days
- Reduced sinus obstruction and improved impaired sense of smell
Treatment with SINUVA resulted in fewer patients still needing sinus surgery
How Safe and Effective is Sinuva?
SINUVA was proven to shrink nasal polyps and reduced symptoms of nasal obstruction and congestion for up to 90 days because it is placed directly among the nasal polyps. It provides targeted, continuous symptom relief, with a low rate of side effects.
In clinical trials:
SINUVA demonstrated similar local effects and hypersensitivity reactions compared to daily steroid nasal spray alone
Patients treated with SINUVA and patients treated with daily steroid nasal spray alone experienced similar rates of side effects
The most common side effects were asthma, headache, and nosebleed. The most common side effects observed (in more than 1% of subjects and that occurred more frequently in patients who received SINUVA compared to patients who were given daily steroid nasal spray) in clinical studies were bronchitis, upper respiratory or middle ear infection, headache, lightheadedness, asthma, and nosebleed.
